H. Heidrich et al., QUALITY-OF-LIFE IN PERIPHERAL ARTERIAL OC CLUSIVE-DISEASE - MULTICENTER STUDY OF LIFE QUALITY BY A NEWLY DEVELOPED DISEASE-SPECIFIC QUESTIONNAIRE, Medizinische Klinik, 90(12), 1995, pp. 693-697
Aim: Owing to a lack of disease-specific measuring instruments, no sys
tematic investigations of the impairment of the quality of life in pat
ients with peripheral arterial occlusive disease (PAOD) have so far be
en possible. The aim of the present study, therefore, was to develop a
n appropriate questionnaire and to submit it to a psychometric test in
a sufficiently large number of patients. Patients and method: A disea
se-specific questionnaire comprising 86 individual items was developed
(PAVK 86) and was tested in a longitudinal study involving 308 patien
ts with confirmed peripheral arterial occlusive disease, Fontaines's s
tages I to IV. At the same time, three established generic questionnai
res were also employed (SF 36, NHP, Every Day Life). Results: Analysis
showed that, in comparison with a normal population, the quality of l
ife in patients with PAOD is considerably impaired, in particular by p
ain, anxiety, general complaints and reduced physical mobility and per
formance, and is comparable with that of patients suffering from renal
carcinoma. In Fontaine's stage III and IV, the quality of life is sig
nificantly more greatly impaired than in patients with stage II diseas
e. No differences in quality of life were to be found between Fontaine
's stages III and IV. The psychometric test revealed that the PAVK 86
questionnaire is a sensitive, reliable, valid and practicable measurin
g instrument. Conclusion: The PAVK 86 questionnaire is suitable for de
termining the course and outcome of therapeutic measures on the qualit
y of life of PAOD patients, and can therefore be included in clinical
studies, In addition, its use in combination with established generic
questionnaires also permits a comparison with age-matched healthy cont
rol groups, and is thus also of importance for the assessment of aspec
ts of health economics.